HIV Vaccines

Steven D. Pinkerton and Paul R. Abramson
Additional contact information
Steven D. Pinkerton: University of California, Los Angeles
Paul R. Abramson: University of California, Los Angeles

Evaluation Review, 1993, vol. 17, issue 6, 579-602

Abstract: The development of an effective preventive vaccine against the human immunodeficiency virus (HIV) is an urgent national and international priority. However, a number of formidable obstacles, encompassing biomedical, logistic, economic, social, and psychosocial concerns, must be overcome to ensure the proper distribution and use of an HIV vaccine once it is developed

Date: 1993
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0193841X9301700601 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:evarev:v:17:y:1993:i:6:p:579-602

DOI: 10.1177/0193841X9301700601

Access Statistics for this article

More articles in Evaluation Review
Bibliographic data for series maintained by SAGE Publications ().